Literature DB >> 27297182

Pi inhibits intracellular accumulation of methylglyoxal in promastigote form of L. donovani.

Praachi Tiwari1, Pankaj Verma1, Amit Kumar Kureel1, Sheetal Saini1, Ambak Kumar Rai2.   

Abstract

Similar to their mammalian counterpart, protozoan parasites including Leishmania donovani detoxify methylglyoxal (MG),(1) a toxic ubiquitous product generated in glycolysis pathway. However, it differs in one or more way(s) from the humans. It is known that MG is eliminated either through glyoxalase (GLO)(2) pathway and/or excreted across the cell membrane. This toxic metabolic by-product is known to be detoxified predominantly by the GLO pathway and excretion across the cell membrane is never considered to be a significant pathway for its detoxification. We have tried to modulate these pathways under various physiological conditions to find ways that may lead to accumulation of MG in L. donovani. Besides targeting the GLO pathway, we intend to understand the mechanism of MG release across the cell membrane and possible ways to inhibit its exclusion from parasites. In our study, it was found that inorganic phosphate (Pi)(3) in the presence of glucose inhibits the production of MG as well as promotes the expulsion of MG from the cell. Moreover, the trivalent form of antimony (Sb(III)) inhibits GLO pathway and thus detoxification of MG. Inhibition of Pi transport, which is a Na(+)/H(+) dependent process, restores the Pi mediated abrogation of MG production. Thus, Sb(III) along with inhibitors of Pi transporter may be a therapeutic advancement for treatment of antimony resistant cases of human visceral leishmaniasis. However, it requires further validation using specific inhibitor(s) of Pi transporter.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glucose; Glyoxalase pathway; Inorganic phosphate; Leishmania; Methylglyoxal; Trivalent antimony

Mesh:

Substances:

Year:  2016        PMID: 27297182     DOI: 10.1016/j.molbiopara.2016.06.005

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  4 in total

1.  Comparison Between Immuno-Clinicopathological Features of Experimental and Human Visceral Leishmaniasis by Leishmania donovani.

Authors:  Sheetal Saini; Anuradha Dube; Amogh Anant Sahasrabuddhe; Chandreshwar Prasad Thakur; Sumit Joshi; Keerti Rawat; Ambak Kumar Rai
Journal:  Acta Parasitol       Date:  2019-10-01       Impact factor: 1.440

2.  Leishmania donovani reduces the levels of retinoic acid-synthesizing enzymes in infected macrophages and favoring its own survival.

Authors:  Pankaj Verma; Amit Kumar Kureel; Sheetal Saini; Satya Prakash; Smita Kumari; Sarath Kumar Kottarath; Sandeep Kumar Srivastava; Madhusudan Bhat; Amit Kumar Dinda; Chandreshwar Prasad Thakur; Shivesh Sharma; Ambak Kumar Rai
Journal:  Parasitol Res       Date:  2018-10-18       Impact factor: 2.289

3.  Linoleic Acid Inhibits the Release of Leishmania donovani Derived Microvesicles and Decreases Its Survival in Macrophages.

Authors:  Sheetal Saini; Ambak Kumar Rai
Journal:  Front Cell Infect Microbiol       Date:  2020-08-07       Impact factor: 5.293

4.  ZnO and TiO2 nanoparticles alter the ability of Bacillus subtilis to fight against a stress.

Authors:  Elise Eymard-Vernain; Sylvie Luche; Thierry Rabilloud; Cécile Lelong
Journal:  PLoS One       Date:  2020-10-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.